MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 197 filers reported holding MYRIAD GENETICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,130 | -52.9% | 70,472 | -31.8% | 0.01% | -62.1% |
| Q1 2023 | $2,399 | +342.6% | 103,309 | +176.3% | 0.03% | +262.5% |
| Q4 2022 | $542 | -99.9% | 37,393 | -10.6% | 0.01% | 0.0% |
| Q1 2022 | $1,053,000 | +88.7% | 41,813 | +48.1% | 0.01% | -27.3% |
| Q4 2020 | $558,000 | +9.8% | 28,227 | -27.7% | 0.01% | -26.7% |
| Q3 2020 | $508,000 | – | 39,024 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,000,000 | $45,360,000 | 2.60% |
| Tieton Capital Management, LLC | 166,441 | $1,887,000 | 2.36% |
| S&T BANK/PA | 315,835 | $3,582,000 | 0.82% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,194,204 | $24,882,000 | 0.60% |
| XTX MARKETS LLC | 14,807 | $168,000 | 0.57% |
| Glenview Capital Management | 1,810,727 | $20,534,000 | 0.57% |
| EARNEST PARTNERS LLC | 4,761,082 | $53,991,000 | 0.51% |
| AIMZ Investment Advisors, LLC | 42,685 | $484,000 | 0.31% |
| DUALITY ADVISERS, LP | 163,717 | $1,857,000 | 0.17% |
| Engineers Gate Manager LP | 219,922 | $2,494,000 | 0.13% |